NASDAQ: CELUCelularity Inc Stock Ownership - Who owns Celularity?
Insider buying vs selling
Have Celularity Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| David C. Beers | Chief Financial Officer | 2025-04-13 | 360 | $1.64 | $590.40Sell |
| John R. Haines | Senior Exec Vice President | 2025-04-13 | 577 | $1.64 | $946.28Sell |
| Robert J. Hariri | Chief Executive Officer | 2025-04-13 | 1,154 | $1.64 | $1.89kSell |
| Stephen Brigido | Pres. Functional Regeneration | 2025-04-13 | 268 | $1.64 | $439.52Sell |
| David C. Beers | Chief Financial Officer | 2025-02-17 | 4,396 | $2.14 | $9.41kSell |
| Stephen Brigido | Pres. Functional Regeneration | 2025-02-17 | 3,272 | $2.14 | $7.00kSell |
| John R. Haines | Senior Exec Vice President | 2025-02-17 | 7,035 | $2.14 | $15.05kSell |
| Kok Thay Lim | 10% Owner | 2025-01-24 | 535,274 | $2.07 | $1.11MBuy |
| Kok Thay Lim | 10% Owner | 2025-01-24 | 652,981 | $2.07 | $1.35MBuy |
CELU insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CELU insiders and whales buy or sell their stock.
CELU Shareholders
What type of owners hold Celularity Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Kok Thay Lim | 151.99% | 36,400,939 | $60.79M | Insider |
| Dragasac Ltd | 125.53% | 30,062,778 | $50.20M | Insider |
| Starr International Co Inc | 63.81% | 15,281,389 | $25.52M | Insider |
| Sorrento Therapeutics Inc | 21.09% | 5,050,427 | $8.43M | Insider |
| Jay R. Bloom | 7.35% | 1,761,253 | $2.94M | Insider |
| Adrian Kilcoyne | 4.69% | 1,122,238 | $1.87M | Insider |
| John Sculley | 4.19% | 1,004,660 | $1.68M | Insider |
| Dean C. Kehler | 3.33% | 797,858 | $1.33M | Insider |
| C V Starr Co Inc | 3.19% | 764,069 | $1.28M | Institution |
| Vanguard Group Inc | 2.09% | 500,132 | $835.22k | Institution |
CELU vs Biotech Stocks
Celularity Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.